Mirimus
Producer of custom genetically-engineered mouse models with reverse gene silencing capabilities.
Launch date
Employees
Market cap
-
Enterprise valuation
€7—11m (Dealroom.co estimates Mar 2011.)
New York City New York (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $2.0m | Series A | |
$189k | Grant | ||
$1.4m | Grant | ||
$235k | Grant | ||
| N/A | $1.0m | Grant | |
$2.0m | Grant | ||
$2.9m | Grant | ||
$1.0m | Grant | ||
| N/A | $400k | Grant | |
| Total Funding | €10.1m | ||
Related Content
Recent News about Mirimus
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.